Cue Biopharma, Inc. (CUE)
27.44
-0.23
(-0.83%)
USD |
NASDAQ |
Sep 04, 16:00
27.34
-0.10
(-0.36%)
After-Hours: 20:00
Cue Biopharma Cash and Short Term Investments (Annual) : 27.14M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 27.14M |
| December 31, 2024 | 22.46M |
| December 31, 2023 | 48.51M |
| December 31, 2022 | 76.29M |
| December 31, 2021 | 64.37M |
| December 31, 2020 | 84.87M |
| Date | Value |
|---|---|
| December 31, 2019 | 59.41M |
| December 31, 2018 | 39.26M |
| December 31, 2017 | 63.58M |
| December 31, 2016 | 14.98M |
| December 31, 2015 | 6.455M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 215.46M |
| Fortress Biotech, Inc. | 79.38M |
| Equillium, Inc. | 30.28M |
| Legend Biotech Corp. | 948.60M |
| Nurix Therapeutics, Inc. | 592.94M |